viatrexx-mesenchyme- adrenal, ascorbic acid, bdnf, dhea, malic acid, bfgf, fucus vesiculosus, histidine, hyaluronidase, il-6, la
viatrexx bio incorporated - bos taurus adrenal gland (unii: m2776swb29) (bos taurus adrenal gland - unii:m2776swb29), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), brain-derived neurotrophic factor human (unii: 7171wsg8a2) (brain-derived neurotrophic factor human - unii:7171wsg8a2), prasterone (unii: 459ag36t1b) (prasterone - unii:459ag36t1b), malic acid (unii: 817l1n4ckp) (malic acid - unii:817l1n4ckp), basic fibroblast gro - viatrexx-mesenchyme a sterile, injectable, biodegradable, clear isotonic liquid that is injected into the various layers of the skin, muscles, ligaments, joints, other body tissues or added to an iv, either as a push or into the bag. this product should not be used in patients with a known hypersensitivity to any ingredient found in the formula, porcine products, isotonic saline or benzyl alcohol, or patients with a history of severe allergies. as with all injections, epinephrine injection (1:1,000) must be immediately available should an acute anaphylactoid reaction occur due to any component of the injection. this product contains 1% benzyl alcohol. benzyl alcohol has been reported to be associated with a fatal "gasping syndrome" in premature infants. due to the benzyl alcohol content, this product should not be given to a pregnant woman. this product should not be used in patients with a known hypersensitivity to any ingredient in this formula, porcine products, isotonic saline or benzyl alcohol, or patie
dbl sterile cardioplegia concentrate
hospira australia pty ltd - procaine hydrochloride; magnesium chloride; potassium chloride -
dbl sterile cardioplegia concentrate injection ampoule
pfizer australia pty ltd - magnesium chloride hexahydrate,potassium chloride,procaine hydrochloride -
lasonil
bayer new zealand limited - heparinoids 50 hdbu/g; hyaluronidase 150 iu/g - topical ointment - active: heparinoids 50 hdbu/g hyaluronidase 150 iu/g
lasonil 5000/15000 %v/v ointment
bayer plc - heparinoid hyaluronidase - ointment - 5000/15000 %v/v
lasonil oint ointment
bayer pharma ag, germany - heparinoid, hyaluronidase - ointment
hyqvia 20 g/200 ml
1 glass vial human normal immunoglobulin (200ml) + 1 vial recombinant human hyaluronidase (10 ml) -
hyqvia 2.5 g/25 ml
1 glass vial human normal immunoglobulin (25ml) + 1 vial recombinant human hyaluronidase (1.25 ml) -
hyqvia 5 g/50 ml
1 glass vial human normal immunoglobulin (50ml) + 1 vial recombinant human hyaluronidase (2.5 ml) -
hyqvia 10 g/100 ml
1 glass vial human normal immunoglobulin (100ml) + 1 vial recombinant human hyaluronidase (5 ml) -